ICU Medical IncICUI
Price$157.18Intrinsic value$121.5223% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.2B-9.3% YoYTTM through 30 Jun 2026
Net Income $46.3MTTM through 30 Jun 2026
Free Cash Flow $152.8MTTM through 30 Jun 2026

Margins

Current
Gross Margin38.9%
EBITDA Margin12.7%
Operating Margin2.6%
Net Margin5.7%

Returns

1.4%ROE
0.8%ROA
1.0%ROIC

Balance Sheet Health

Debt / Equity0.61x
Current Ratio2.34x
Net Debt$992.2M
Cash & Equivalents$298.3M

Quality Metrics

Altman Z-Score2.41
FCF Margin7.1%
Rule of 408.5
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.2B
Diluted EPS$1.19TTM
'19'20'21'22'23'24'25
FY2025: $0.03

Dividend

No dividend

Capital Allocation

R&D Spend$86.3M
Capex Intensity3.9%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.